Try our Advanced Search for more refined results
Mergers & Acquisitions
-
November 07, 2025
Spurned Pfizer Turns To Antitrust Law To Reclaim Biotech
What may be a first-of-its-kind lawsuit is playing out as Pfizer Inc. turns to antitrust law to keep Novo Nordisk from usurping its bid for Metsera.
-
November 07, 2025
9th Circ. Pushed To Revive Suit Over $3.8B Failed Tech Merger
A California federal judge erred in finding that investors in semiconductor company MaxLinear Inc. had no standing to sue it over what they say were misrepresentations about a $3.8 billion merger plan with chipmaker Silicon Motion Technology Corp., they told the Ninth Circuit in a bid to revive their suit.
-
November 07, 2025
Javice Tells Chancery JPMorgan Is Stalling Appeal Fees
Charlie Javice, the convicted founder of college financial aid startup Frank, has told a Delaware judge that JPMorgan Chase & Co. is effectively trying to cut off her ability to appeal her criminal conviction by refusing to advance the vast majority of her ongoing legal fees.
-
November 07, 2025
3 Firms Guide Dubai Hookah Maker's $1.75B SPAC Merger
Three law firms are guiding Dubai hookah brand owner AIR Ltd. on its agreement to go public in the U.S. through a $1.75 billion deal with blank-check firm Cantor Equity Partners III, the companies said on Friday.
-
November 07, 2025
Beauty Co. Says Ex-Exec's $40M Claim 'Implausible'
The former president of a Connecticut beauty brand that L'Oréal bought for around $1 billion has made an "implausible" claim that she is owed $40 million from the sale based on an alleged verbal contract, the company said in opposing her application for a prejudgment remedy.
-
November 07, 2025
Trump Media Q3 Loss Widens On Rising Legal Costs
Truth Social operator Trump Media & Technology Group Corp. on Friday reported larger third-quarter losses than in the year prior due to growing legal expenses related to a special purpose acquisition company merger that took President Donald Trump's media company public last year.
-
November 07, 2025
Taxation With Representation: Kirkland, Cravath, Paul Weiss
In this week's Taxation With Representation, consumer products giant Kimberly-Clark acquires Tylenol maker Kenvue, shale producers SM Energy and Civitas Resources announce a merger, and power management company Eaton buys Boyd Corp.'s thermal business.
-
November 07, 2025
Papa John's CEO Addresses 'M&A Rumors' In Q3 Call
Days after private equity giant Apollo was said to have pulled a roughly $2.1 billion offer to purchase Papa John's, CEO Todd Penegor said Friday that the pizza chain would "fully consider" future strategic alternatives.
-
November 07, 2025
Laborie Buys Postpartum Bleeding Device For Up To $465M
Medical technology company Laborie Medical Technologies, advised by Simpson Thacher & Bartlett LLP and Cooley LLP, unveiled plans Friday to acquire a postpartum uterine bleeding device from New Jersey-based healthcare company Organon for up to $465 million.
-
November 07, 2025
Solar Co. Pine Gate Hits Ch. 11 With $1B+ Debt, Sale Plan
Solar energy developer Pine Gate Renewables has filed for Chapter 11 protection in a Texas bankruptcy court with more than $1 billion in debt and a plan to sell its business during the case.
-
November 07, 2025
Wheaton Precious Metals To Buy US Gold Project For $670M
Canada-based Wheaton Precious Metals Corp. said Friday that it will add a U.S. gold mine from Waterton Gold LP to its portfolio in a $670 million cash deal.
-
November 07, 2025
UK Open To Fixes In Greencore's £1.2B Bakkavor Deal
The Competition and Markets Authority said Friday that it is likely to accept proposals by Greencore to sell its manufacturing plant for chilled sauces to get its £1.2 billion ($1.6 billion) deal for rival Bakkavor over the line.
-
November 06, 2025
CareFirst Urges Ban On J&J Character Talk At Stelara Trial
Health insurer CareFirst is asking a Virginia federal judge to bar Johnson & Johnson from promoting its "good character" to a jury that will weigh class claims of anticompetitive conduct and patent fraud to extend market protection on the blockbuster autoimmune drug Stelara.
-
November 06, 2025
Core Scientific Reaches $14.75M Deal With SPAC Investors
Bankrupt cryptocurrency miner Core Scientific has reached a $14.75 million agreement to settle proposed class action claims brought by an investor in the special purpose acquisition company that made a $4.3 billion deal to bring the miner public via merger.
-
November 06, 2025
Six Flags Faces Investor Suit Over Troubled Turnaround Bid
Amusement park giant Six Flags Entertainment Corp. faces a proposed investor class action alleging the company failed to effectively capitalize on its 2024 merger with another theme park operator, precipitating a "catastrophic" earnings miss in August.
-
November 06, 2025
Edwards Defends $945M Heart Valve Deal From FTC Challenge
Edwards Lifesciences urged a D.C. federal court to reject the Federal Trade Commission's bid to put its planned $945 million acquisition of JenaValve on hold, saying the deal will increase innovation and save the lives of thousands of people with a form of heart valve disease.
-
November 06, 2025
4 Firms Guide Go-Private Deal, $1.16B Casinos Sale
Gaming and hospitality company Golden Entertainment Inc.'s CEO Blake L. Sartini and affiliates have agreed to buy the company's operating assets, while real estate investment trust VICI Properties Inc. also agreed to pay $1.16 billion for a seven-property Golden Entertainment portfolio, Golden Entertainment and VICI announced Nov. 6.
-
November 06, 2025
AI Developer Made $100M By Dumping Tokens, Suit Says
A purported open-source artificial intelligence developer has been hit with a proposed class action accusing it of reaping over $100 million in ill-gotten gains by manipulating a token merger and breaching a covenant to develop AI tools in an "ethical and acceptable manner."
-
November 06, 2025
Charles Schwab Making $660M Push Into Private Markets
The Charles Schwab Corp. said Thursday it has agreed to acquire Forge Global Holdings Inc. in a transaction valued at approximately $660 million, in a deal guided by three firms that marks the financial services company's latest effort to dive deeper into private markets.
-
November 06, 2025
Pfizer Matches Novo's $10B Metsera Bid, And Other Rumors
Pfizer Inc. reportedly raised its offer for Metsera Inc. to match a $10 billion bid from Novo Nordisk Inc., as a bidding war and legal squabble play out between the drugmakers. Among other deal-related rumors, Apollo Global Management Inc. reportedly dropped its bid to take private pizza chain Papa Johns International Inc., and new developments emerged as Warner Bros. Discovery Inc. weighs potential sale options.
-
November 06, 2025
Akerman Adds Alternative Investments Pro From Crowell
Akerman LLP announced on Wednesday that it has hired a former Crowell & Moring LLP attorney with a history of working in-house for institutional investment firms.
-
November 06, 2025
Skadden, Debevoise Lead Aquarian's $4.1B Brighthouse Buy
Skadden and Debevoise are advising on a new agreement for Aquarian Capital to purchase U.S. life insurer Brighthouse Financial Inc. in an all-cash transaction valued at about $4.1 billion, the companies announced Thursday.
-
November 06, 2025
EchoStar Sells Spectrum Licenses To SpaceX In $2.6B Deal
Telecommunications company EchoStar, led by White & Case LLP, announced Thursday that it agreed to sell certain licenses to Elon Musk-controlled SpaceX in a $2.6 billion stock deal that builds on a previous agreement they entered into earlier this year.
-
November 06, 2025
Another Kirkland Investment Funds Atty Joins V&E In Houston
Vinson & Elkins LLP has continued expanding its investment funds practice with a partner in Houston who is the third to join the practice from Kirkland & Ellis LLP since June.
-
November 06, 2025
Shell, Equinor Merger Faces Enviro Calls For UK Tax Probe
Environmentalist groups urged HM Treasury on Thursday to investigate the alleged £1.3 billion ($1.7 billion) tax savings that energy businesses Shell and Equinor will make if they merge their U.K. operations.
Expert Analysis
-
Series
Law School's Missed Lessons: Learning From Failure
While law school often focuses on the importance of precision, correctness and perfection, mistakes are inevitable in real-world practice — but failure is not the opposite of progress, and real talent comes from the ability to recover, rethink and reshape, says Brooke Pauley at Tucker Ellis.
-
Legal Ops, Compliance Increasingly Vital To Antitrust Strategy
With deal timelines tightening and disclosure requirements intensifying, legal operations and compliance teams are becoming critical drivers of premerger strategy, cross-functional alignment and regulatory credibility, says Alexander Lima at Wesco International.
-
Series
Adapting To Private Practice: From ATF Director To BigLaw
As a two-time boomerang partner, returning to BigLaw after stints as a U.S. attorney and the director of the Bureau of Alcohol, Tobacco, Firearms and Explosives, people ask me how I know when to move on, but there’s no single answer — just clearly set your priorities, says Steven Dettelbach at BakerHostetler.
-
4th Circ. Favors Plain Meaning In Bump-Up D&O Ruling
The Fourth Circuit's latest denial of indemnity coverage in Towers Watson v. National Union Fire Insurance and its previous ruling in this case lay out a pragmatic approach to bump-up provisions that avoids hypertechnical constructions to limit the effect of a policy's plain meaning, say attorneys at Kennedys.
-
Opinion
DOJ's HPE-Juniper Settlement Will Help US Compete
The U.S. Department of Justice settlement with Hewlett Packard Enterprise clears the purchase of Juniper Networks in a deal that positions the U.S. as a leader in secure, scalable networking and critical digital infrastructure by requiring the divestiture of a WiFi network business geared toward small firms, says John Shu at Taipei Medical University.
-
Series
Playing Baseball Makes Me A Better Lawyer
Playing baseball in college, and now Wiffle ball in a local league, has taught me that teamwork, mental endurance and emotional intelligence are not only important to success in the sport, but also to success as a trial attorney, says Kevan Dorsey at Swift Currie.
-
Building Better Earnouts In The Current M&A Climate
In the face of market uncertainty, we've seen a continued reliance on earnouts in M&A deals so far this year, but to reduce the risk of related litigation, it's important to use objective standards, apply company metrics cautiously and ensure short time periods, among other best practices, say attorneys at White & Case.
-
Series
Law School's Missed Lessons: Skillful Persuasion
In many ways, law school teaches us how to argue, but when the ultimate goal is to get your client what they want, being persuasive through preparation and humility is the more likely key to success, says Michael Friedland at Friedland Cianfrani.
-
A Look At Trump 2.0 Antitrust Enforcement So Far
The first six months of President Donald Trump's second administration were marked by aggressive antitrust enforcement tempered by traditional structural remedies for mergers, but other unprecedented actions, like the firing of Federal Trade Commission Democrats, will likely stoke heated discussion ahead, says Richard Dagen at Axinn.
-
Litigation Inspiration: How To Respond After A Loss
Every litigator loses a case now and then, and the sting of that loss can become a medicine that strengthens or a poison that corrodes, depending on how the attorney responds, says Bennett Rawicki at Hilgers Graben.
-
The Metamorphosis Of The Major Questions Doctrine
The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.
-
Biotech Collaborations Can Ease Uncertainty Amid FDA Shift
As concerns persist that the U.S. Food and Drug Administration's reduced headcount will impede developments at already-strapped biotech companies, licensing and partnership transactions can provide the necessary funding and pathways to advance innovative products, say attorneys at Troutman.
-
Series
Playing Mah-Jongg Makes Me A Better Mediator
Mah-jongg rewards patience, pattern recognition, adaptability and keen observation, all skills that are invaluable to my role as a mediator, and to all mediating parties, says Marina Corodemus.
-
Business Court Bill Furthers Texas' Pro-Corporate Strategy
The Texas Legislature's recent bill to enhance corporate protections and expand access to the Texas Business Court by refining its jurisdictional standards is just the latest step in the state's playbook for becoming the new center of corporate America, say attorneys at Katten.
-
FTC Staff Cuts Unlikely To Curb Antitrust Enforcement Agenda
While Federal Trade Commission Chair Andrew Ferguson's recent commitment to reducing agency staff may seem at odds with the Trump administration's commitment to antitrust enforcement, a closer analysis shows that such reductions have little chance of derailing the president's efforts, say attorneys at Squire Patton.